Most recently, Kinaset Therapeutics raised $103.0M in its Later Stage VC (Series B) (Jan 2026).
- ·The complete investor list: 12 names
- ·Watch Kinaset Therapeutics: the Monday email on marks, rounds and moves
Kinaset Therapeutics round by round
3 roundsHow much has Kinaset Therapeutics raised?
Kinaset Therapeutics has raised $143 million across 3 recorded rounds since 2020. The largest was a $28.5 million early-stage round in Jul 2022; the most recent was a $103 million Series B in Jan 2026.
Kinaset Therapeutics has filed 3 Form Ds with the SEC since 2020, most recently in Jul 2023 ($28.5 million sold to 3 investors).
Kinaset Therapeutics investors
12 investors are on record for Kinaset Therapeutics, including RA Capital Management, SV Health Investors, EQT Life Sciences and Schroders Capital. By type, the record holds 3 venture capital firms and 2 asset managers. The Series B in Jan 2026 drew 11 investors.
12 investors have backed Kinaset Therapeutics — start your target list with the firms already writing checks in drug discovery.
Frequently asked about Kinaset Therapeutics
- How much has Kinaset Therapeutics raised?
- Kinaset Therapeutics has raised $143.0M in total across 3 recorded funding rounds.
- When was Kinaset Therapeutics's last funding round?
- Kinaset Therapeutics's most recent recorded round was Later Stage VC (Series B) in Jan 2026, raising $103.0M.